Send me a link:

*Text messaging rates may apply.

 Dow Down 0.74% Nasdaq Down 0.49%

Endocyte, Inc. (ECYT)

-NasdaqGS
6.27 Down 0.04(0.65%) 2:47PM EDT - Nasdaq Real Time Price
Prev Close:6.31
Open:6.25
Bid:6.18 x 2400
Ask:6.19 x 1800
1y Target Est:13.72
Beta:0.89
Next Earnings Date:29-Jul-14ECYT Earnings announcement
Day's Range:6.17 - 6.35
52wk Range:6.01 - 33.70
Volume:407,099
Avg Vol (3m):1,548,060
Market Cap:260.19M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ECYT

Comparison

Symbol% ChgMkt Cap
ECYTDown 0.65%260.19M
NKTRDown 0.27%1.39B
RHHBYDown 0.81%250.90B
SNSSUp 3.29%396.83M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.18
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback